A retrospective analysis of 60 case reports revealed that post-COVID-19 vaccination Guillain-Barre syndrome (GBS) occurred mostly after the first dose

A retrospective analysis of 60 case reports revealed that post-COVID-19 vaccination Guillain-Barre syndrome (GBS) occurred mostly after the first dose